Proteomics to Identify Disease-Associated Variants in Patients with Rare Disease Undiagnosed After Genome Sequencing
Wednesday, January 27, 2027 at 11:30 AM to 12:00 PM · 30 min. (Europe/London)
Multi-Omics Stage
Day 1 - Wednesday 27th January
Proteomics
Information
In this session you can expect to cover:
Discussion our proof-of-principle study to explore the potential of circulating proteomics to improve the diagnostic yield in patients with rare diseases from the 100,000 Genomes project (100kGP)
Detection of lower serum protein ‘outliers’ can help resolve VUS or prioritise genes for targeted reanalysis of GS data to provide genetic diagnoses to undiagnosed patients after WGS.
Broad-capture blood proteomic technologies can support identification of new candidate rare disease genes.